SPS
ABBV icon

Susquehanna Portfolio Strategies’s AbbVie ABBV Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,891
Closed -$4.54M – 960
2025
Q4 		$4.54M Buy
+19,891
New +$4.53M 0.07% 320
2024
Q2 		– Sell
-34,814
Closed -$6.34M – 501
2024
Q1 		$6.34M Hold
34,814
– – 0.15% 180
2023
Q4 		$5.4M Buy
+34,814
New +$5.08M 0.1% 271

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna Portfolio Strategies's ABBV Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 19,891 shares — an estimated $4.54M sold.

Susquehanna Portfolio Strategies first reported a position in ABBV in Q4 2023 and held it in 3 quarters. The position peaked at $6.34M in Q1 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 19,891 AbbVie shares in Q1 2026, an estimated $4.54M.
  • Susquehanna Portfolio Strategies first reported a position in AbbVie in Q4 2023 and held it in 3 quarters.
  • Susquehanna Portfolio Strategies's AbbVie position peaked at $6.34M in Q1 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.